1. Home
  2. CTAS vs REGN Comparison

CTAS vs REGN Comparison

Compare CTAS & REGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cintas Corporation

CTAS

Cintas Corporation

N/A

Current Price

$195.68

Market Cap

79.9B

ML Signal

N/A

Logo Regeneron Pharmaceuticals Inc.

REGN

Regeneron Pharmaceuticals Inc.

N/A

Current Price

$738.65

Market Cap

81.1B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CTAS
REGN
Founded
1968
1988
Country
United States
United States
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
79.9B
81.1B
IPO Year
1994
1995

Fundamental Metrics

Financial Performance
Metric
CTAS
REGN
Price
$195.68
$738.65
Analyst Decision
Buy
Buy
Analyst Count
20
27
Target Price
$218.31
★ $850.88
AVG Volume (30 Days)
★ 1.8M
526.1K
Earning Date
09-23-2026
10-30-2026
Dividend Yield
★ 1.07%
0.50%
EPS Growth
★ 11.59
8.19
EPS
4.91
★ 18.95
Revenue
★ $6,892,303,000.00
$5,872,227,000.00
Revenue This Year
$8.71
$18.35
Revenue Next Year
$7.53
$9.19
P/E Ratio
$40.12
★ $39.41
Revenue Growth
N/A
★ 20.82
52 Week Low
$161.16
$541.00
52 Week High
$219.17
$859.34

Technical Indicators

Market Signals
Indicator
CTAS
REGN
Relative Strength Index (RSI) 44.77 41.97
Support Level $191.72 $758.85
Resistance Level $197.47 $782.44
Average True Range (ATR) 3.93 18.21
MACD -0.25 -6.08
Stochastic Oscillator 35.62 28.05

Price Performance

Historical Comparison
CTAS
REGN

About CTAS Cintas Corporation

Cintas has roots dating back to 1929, when the Farmer family cleaned and resold dirty rags to manufacturing plants in Ohio. The firm has expanded its business organically and through acquisitions, and today Cintas acts as a one-stop outsourcing partner for businesses. Cintas will design, manufacture, collect, and clean every employee uniform for a small weekly sum, taking on the upfront capital expense itself. At the same stop, Cintas can also replace soiled or depleted mats, mops, trash liners, towels, first aid supplies, fire extinguishers, and cleaning products. Businesses value an outsourcing partner like Cintas as it simplifies operations and leaves noncore tasks with high regulatory standards in the hands of professionals.

About REGN Regeneron Pharmaceuticals Inc.

Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including low-dose Eylea and Eylea HD, approved for wet age-related macular degeneration and other eye diseases; Dupixent in immunology; Praluent for LDL cholesterol lowering; Libtayo in oncology; Kevzara in rheumatoid arthritis; and Lynozyfic for multiple myeloma. Regeneron has multiple partnerships and collaboration agreements, with Sanofi (Dupixent, others) and Bayer (Eylea) as its largest partners.

Share on Social Networks: